scholarly journals Age, Race, and At-Risk Drinking in an HIV-infected U.S. Military Cohort

2019 ◽  
Vol 184 (5-6) ◽  
pp. e263-e267
Author(s):  
Morgan Byrne ◽  
Robert Deiss ◽  
Octavio Mesner ◽  
Margaret Glancey ◽  
Anuradha Ganesan ◽  
...  

Abstract Introduction There is a high prevalence of at-risk drinking in the U.S. military. Among HIV-infected individuals, alcohol abuse confers additional risk for adverse health outcomes. In the military, however, the characteristics of HIV-infected individuals who engage in high-risk drinking are not well defined. The purpose of this study was to assess risk factors associated with at-risk drinking in an HIV-positive longitudinal cohort of DoD beneficiaries. Materials and Methods Annual prevalence of at-risk drinking was calculated for members of the U.S. Military HIV Natural History Study who initiated highly active antiretroviral therapy (HAART) during or after January 2006 through May 2014; each participant completed at least one self-reported alcohol survey within a year of HAART initiation. Univariate and multivariable logistic regression was used to analyze factors associated with at-risk drinking. Results Sixty-six percent of subjects (495/752) reported at-risk drinking on at least one survey after HAART initiation. At-risk drinkers were more likely to be Active Duty compared to Retired (OR 0.65 95% CI [0.46, 0.92]). In multivariate models, Caucasian race (OR 3.30 95% CI [2.31, 4.71]); Hispanic/other race (OR 2.17 95% CI [1.51, 3.14]) and younger age (OR 0.61 per 10 years older, [95%CI 0.49, 0.75]) were significantly associated with at-risk drinking. Single relationship status (OR 1.51 95% CI [1.08, 2.13]) was also associated with at-risk drinking. Conclusions Consistent with general alcohol consumption patterns in the military, we found a high prevalence of at-risk drinking among individuals with HIV infection, which was associated most closely with young, non-African Americans. Targeting interventions toward this group will be important to reduce at-risk drinking and its potential for HIV-related complications.

2010 ◽  
Vol 52 (3) ◽  
pp. 378-386 ◽  
Author(s):  
K. E. Mondy ◽  
J. Gottdiener ◽  
E. T. Overton ◽  
K. Henry ◽  
T. Bush ◽  
...  

2006 ◽  
Vol 41 (4) ◽  
pp. 477-485 ◽  
Author(s):  
Maria Patrizia Carrieri ◽  
Catherine Leport ◽  
Camelia Protopopescu ◽  
Jill-Patrice Cassuto ◽  
Elisabeth Bouvet ◽  
...  

2015 ◽  
Vol 162 (2) ◽  
pp. 90 ◽  
Author(s):  
Ingrid T. Katz ◽  
Erin Leister ◽  
Deborah Kacanek ◽  
Michael D. Hughes ◽  
Arlene Bardeguez ◽  
...  

2013 ◽  
Vol 6 ◽  
pp. IDRT.S10044 ◽  
Author(s):  
Ballah Akawu Denue ◽  
Mohammed Bashir Alkali ◽  
Ali Usman Abjah ◽  
Ibrahim Musa Kida ◽  
Babajide Ajayi ◽  
...  

Abnormalities of lipid metabolism are common in human immunodeficiency virus (HIV)-infected patients and tend to be accentuated in those receiving antiretroviral therapy, particularly with protease inhibitors (PIs). However, there is a dearth of information on serum lipid profiles and biochemical parameters among treatment-naive HIV-positive patients in our environment. We found that after 24 months of highly active antiretroviral therapy (HAART), there was a significant increase in serum lipids. After 24 months of HAART, renal impairment was associated with a low increase in mean HDL and a high increase in triglycerides (TG). In conclusion, abnormality of serum lipid is common and showed female preponderance among treatment-naive HIV patients in our environment. Patients with HIV infection on HAART should be screened for lipid disorders given their high prevalence as observed in this study, because of its potential for morbidity and mortality in patients on HAART.


Sign in / Sign up

Export Citation Format

Share Document